We randomly allocated aneurysmal SAH patients with a modified Fisher score of 4 , who had been treated with endovascular coil embolization and ventricular drainage , to receive either 2 mg intraventricular tissue plasminogen activator ( TPA ) every 12 h ( maximum 10 mg ) or placebo .